These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2866665)

  • 41. Can diabetes mellitus be induced by medication?
    Saito E; Kafantaris V
    J Child Adolesc Psychopharmacol; 2002; 12(3):231-6. PubMed ID: 12427296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Valproate in the treatment of bipolar disorder].
    Rzewuska M
    Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone.
    Tohen M; Chengappa KN; Suppes T; Baker RW; Zarate CA; Bowden CL; Sachs GS; Kupfer DJ; Ghaemi SN; Feldman PD; Risser RC; Evans AR; Calabrese JR
    Br J Psychiatry; 2004 Apr; 184():337-45. PubMed ID: 15056579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    Vasudev K; Keown P; Gibb I; McAllister-Williams RH
    J Clin Psychopharmacol; 2010 Jun; 30(3):282-5. PubMed ID: 20473063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Are mood stabilizers beneficial in the treatment of schizophrenia?].
    Berle JØ; Spigset O
    Tidsskr Nor Laegeforen; 2005 Jun; 125(13):1809-12. PubMed ID: 16012547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M; Tang X; Wen S; Yue J; Wang H
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sodium valproate and the fetus: a case study and review of the literature.
    Smith J; Whitehall J
    Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of Neutropenia With Valproate and Quetiapine Combination Treatment in Subjects With Acquired Brain Injuries.
    Park HJ; Kim JY
    Arch Phys Med Rehabil; 2016 Feb; 97(2):183-8. PubMed ID: 26427579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Valproate-induced hyperammonemic encephalopathy.
    Chou HF; Yang RC; Chen CY; Jong YJ
    Pediatr Neonatol; 2008 Oct; 49(5):201-4. PubMed ID: 19133574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
    Friis T; Christensen TR; Gerlach J
    Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
    [No Abstract]   [Full Text] [Related]  

  • 52. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous valproate treatment of uncontrollable aggression: a case report.
    Qalbani M; De León OA
    J Clin Psychopharmacol; 2007 Oct; 27(5):529-31. PubMed ID: 17873699
    [No Abstract]   [Full Text] [Related]  

  • 54. Reversible altered consciousness with brain atrophy caused by valproic acid.
    Yamanouchi H; Ota T; Imataka G; Nakagawa E; Eguchi M
    Pediatr Neurol; 2003 May; 28(5):382-4. PubMed ID: 12878301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A population-based study of the comparative effectiveness of second-generation antipsychotics vs older antimanic agents in bipolar disorder.
    Bauer MS; Miller CJ; Li M; Bajor LA; Lee A
    Bipolar Disord; 2016 Sep; 18(6):481-489. PubMed ID: 27650468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lithium and anticonvulsants in bipolar depression].
    Samalin L; Nourry A; Llorca PM
    Encephale; 2011 Dec; 37 Suppl 3():S203-8. PubMed ID: 22212876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
    Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937
    [No Abstract]   [Full Text] [Related]  

  • 58. Valnoctamide as a valproate substitute with low teratogenic potential in mania: a double-blind, controlled, add-on clinical trial.
    Bersudsky Y; Applebaum J; Gaiduk Y; Sharony L; Mishory A; Podberezsky A; Agam G; Belmaker RH
    Bipolar Disord; 2010 Jun; 12(4):376-82. PubMed ID: 20636634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extreme elevation of creatinine phosphokinase levels in neuroleptic malignant syndrome associated with atypical antipsychotics.
    Ladds B; Thomas P; Mejia C; Hauser D
    Am J Psychiatry; 2009 Jan; 166(1):114-5. PubMed ID: 19122020
    [No Abstract]   [Full Text] [Related]  

  • 60. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Huang CC; Wei IH
    Gen Hosp Psychiatry; 2010; 32(4):446.e1-2. PubMed ID: 20633751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.